Type: Prostate cancer
Associate Professor Holst’s team have been working on a new type of anti-cancer drug that can ‘starve’ prostate cancer cells and stop their growth.
This study found that a prostate cancer diagnosis puts Australian men at much higher risk of suicide compared to the general male population.
This project will lead to a clinical trial of a developed test to ensure the right patients receive and benefit from focal therapy for prostate cancer.
Tony Maxwell talks about his involvement in cancer support groups and representing consumers in deciding what research Cancer Council funds.
Researchers at Cancer Council NSW found that compared to the general population, men who survived melanoma have a higher risk of being diagnosed with prostate cancer later in life.
Research has revealed the cost of cancer to the Australian health system to be over $6 billion a year.
Dr Nair-Shalliker’s study also found that adult body size, sexual activity and adolescent sexual development are among the factors that appear to raise the risk of prostate cancer.
For Phil, the highlight of being on the Consumer Review Panel is seeing the variety of different research proposals Cancer Council NSW receives on many different types of cancer.
We found the number of men dying from prostate cancer in Australia is not declining at the rate seen in other countries. New projects are looking at ways to better manage prostate cancer.
Professor Samuel Breit has unlocked a new way of stopping prostate cancer and other common cancers in their tracks through targeting a protein involved in tumour development.